Company Tagline
Leading a new way to fight cancer
Industry Category
Business Keywords
Company Description
Gradalis, Inc. is a clinical-stage biotechnology company focused on developing innovative immunotherapies for various cancer indications. With a proprietary bi-shRNA therapy platform proven in clinical studies, Gradalis is dedicated to pioneering new approaches to cancer treatment.
Located at 2545 Golden Bear Drive, Suite 110, Carrollton, Texas 75006, US, Gradalis is committed to improving patient outcomes through cutting-edge research and development. The company's bi-shRNA platform is designed to silence a broad range of genes applicable to multiple cancer types, marking a significant advancement in the field of immuno-oncology. Gradalis is also located at 8333 Douglas Ave, Dallas, Texas 75225, US.
Gradalis, Inc. is at the forefront of developing next-generation cancer therapies. We invite the manager of Gradalis, Inc. to create a customized and exclusive company showcase and product listing on our platform to further enhance their visibility and commercial development.
Gradalis, Inc. est une société de biotechnologie en phase clinique axée sur le développement d'immunothérapies innovantes pour diverses indications de cancer. Grâce à une plateforme exclusive de thérapie bi-shRNA éprouvée dans des études cliniques, Gradalis se consacre à la promotion de nouvelles approches pour le traitement du cancer.
Située au 2545 Golden Bear Drive, Suite 110, Carrollton, Texas 75006, États-Unis, Gradalis s'engage à améliorer les résultats pour les patients grâce à la recherche et au développement de pointe. La plateforme bi-shRNA de l'entreprise est conçue pour réduire au silence un large éventail de gènes applicables à de nombreux types de cancer, ce qui représente une avancée significative dans le domaine de l'immuno-oncologie. Gradalis est également située au 8333 Douglas Ave, Dallas, Texas 75225, États-Unis.
Gradalis, Inc. est à l'avant-garde du développement de thérapies anticancéreuses de nouvelle génération. Nous invitons le responsable de Gradalis, Inc. à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme afin d'améliorer davantage leur visibilité et leur développement commercial.
Key Personnel / Employees
Compare Companies Side by Side
Compare Gradalis, Inc. with 3 companies in Biotechnology-Research
| Comparison Field |
Gradalis, Inc.Main Company |
PQE GroupView Profile |
Labcorp Drug Develop...View Profile |
Nexa Life SciencesView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 1998 | 0 | 2024 |
|
Company Size
|
— | 1,001-5,000 | 10,001+ | 2-10 |
|
City
|
Carrollton, Texas | Reggello, FI | Burlington,, North Carolina | |
|
Country
|
United States | Italy | ||
|
Skills & Keywords
Comparing with main company
|
10 Total Skills
Biotechnology
Immunotherapy
Cancer Research
Oncology
Pharmaceutical
Clinical Trials
Biotech
Immuno Oncology
CRO
Life Sciences
|
20 Total
20 Unique
Unique Skills:
21 CFR Part 11
Audit
Compliance
CSV
Cybersecurity
Data Integrity
+14
|
36 Total
2 Common
34 Unique
Match
20%
Common Skills:
Clinical Trials
Oncology
Unique Skills:
Bioanalysis
Bioassays
Cell & Gene Therapy
Central Laboratory Services
Central Labs
Clinical Research
+28
|
5 Total
1 Common
4 Unique
Match
10%
Common Skills:
Biotechnology
Unique Skills:
CDMO
Medical Technology
Recruitment
Talent Solutions
|
4
Total Companies1998
Oldest Founded2
Countries68
Unique SkillsSimilar Companies
Other organizations in the same industry
Congruence Therapeutics
Biotechnology-ResearchFrom Topology to Treatments.
Cerapedics Inc.
Biotechnology-ResearchCerapedics is an Orthopedics company aspiring to redefine the standard of care for bone repair.
Alternative Company Names
This company is also known as